What is Amphastar Pharmaceuticals's return on equity?

Amphastar Pharmaceuticals (AMPH) reported return on equity of 14.7% in Q4 2021.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Amphastar Pharmaceuticals AMPH Return on equity

Discontinued — last reported Q4 '21

Return on equity at other companies

PfizerPFE

10.6%—

Halozyme TherapeuticsHALO

124.5%+12.7pp

ViatrisVTRS

-2%-0.9pp

Opko HealthOPK

-16.9%-21.7pp

AptarGroupATR

15%-0.2pp

ARS Pharmaceuticals, Inc.SPRY

-136.4%-144pp

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

net income/total stockholders equity=14.7%

Based on trailing twelve months.

The official record: Amphastar Pharmaceuticals’s 10-K, filed March 1, 2023, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's return on equity?: Amphastar Pharmaceuticals (AMPH) reported return on equity of 14.7% in Q4 2021.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.